New patent expiration for Merck Sharp drug PREVYMIS

Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three…

Source


Comments are closed.

Biotechblog